Japan Post Holdings, an Aflac 10% owner, sells $1.76m in stock By Investing.com
James Woodruff, Chief Scientific Officer at MapLight Therapeutics, Inc. (), engaged in a series of stock sales totaling approximately $673,636 between July 15 and July 17, 2026. These transactions involved the disposition of voting common stock at prices ranging from $36.00